JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M602474200 on September 15, 2006

J. Biol. Chem., Vol. 281, Issue 46, 35070-35080, November 17, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/46/35070    most recent
M602474200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chakraborty, S.
Right arrow Articles by Kao, H.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chakraborty, S.
Right arrow Articles by Kao, H.-Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

{alpha}-Actinin 4 Potentiates Myocyte Enhancer Factor-2 Transcription Activity by Antagonizing Histone Deacetylase 7*

Sharmistha Chakraborty{ddagger}, Erin L. Reineke{ddagger}1, Minh Lam§, Xiaofang Li{ddagger}2, Yu Liu{ddagger}, Chengzhuo Gao{ddagger}, Simran Khurana{ddagger}, and Hung-Ying Kao, An American Cancer Society Research Scholar{ddagger}3

From the {ddagger}Department of Biochemistry, School of Medicine, Case Western Reserve University and the §Research Institute of University Hospitals of Cleveland and the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio 44106

Histone deacetylase 7 (HDAC7) is a member of class IIa HDACs that regulate myocyte enhancer factor-2 (MEF2)-mediated transcription and participate in multiple cellular processes such as T cell apoptosis. We have identified {alpha}-actinin 1 and 4 as class IIa HDAC-interacting proteins. The interaction domains are mapped to C terminus of {alpha}-actinin 4 and amino acids 72-172 of HDAC7. A point mutation in HDAC7 that disrupts its association with MEF2A also disrupts its association with {alpha}-actinin 4, indicating that MEF2A and {alpha}-actinin 4 binding sites largely overlap. We have also isolated a novel splice variant of {alpha}-actinin 4 that is predominantly localized in the nucleus, a pattern distinct from the full-length {alpha}-actinin 4, which is primarily distributed in the cytoplasm and plasma membrane. Using small interfering RNA, chromatin immunoprecipitation, and transient transfection assays, we show that {alpha}-actinin 4 potentiates expression of TAF55, a putative MEF2 target gene. Loss of MEF2A interaction correlates with loss of the ability of {alpha}-actinin 4 to potentiate TAF55 promoter activity. Ectopic expression of {alpha}-actinin 4, but not the mutant defective in MEF2A association, leads to disruption of HDAC7·MEF2A association and enhancement of MEF2-mediated transcription. Taken together, we have identified a novel mechanism by which HDAC7 activity is negatively regulated and uncovered a previously unknown function of {alpha}-actinin 4.


Received for publication, March 16, 2006 , and in revised form, September 14, 2006.

* This project was supported by American Heart Association Grant 0330311N and NIDDK, National Institutes of Health Grant R01 DK62985 (to H.-Y. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by the Case Comprehensive Cancer Center, NCI, National Institutes of Health Research Oncology Training Grant T32 CA059366-11.

2 Present address: College of Life Science, East China Normal University, 3663 N. Zhongshan Rd., Shanghai 200062, China.

3 To whom correspondence should be addressed: Dept. of Biochemistry and the Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106. Tel.: 216-368-1150; Fax: 216-368-1597; E-mail: hxk43{at}po.cwru.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
C. Gao, X. Cheng, M. Lam, Y. Liu, Q. Liu, K.-S. Chang, and H.-Y. Kao
Signal-dependent Regulation of Transcription by Histone Deacetylase 7 Involves Recruitment to Promyelocytic Leukemia Protein Nuclear Bodies
Mol. Biol. Cell, July 1, 2008; 19(7): 3020 - 3027.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. Hiroi, Z. Guo, Y. Li, A. H. Beggs, and J. K. Liao
Dynamic regulation of endothelial NOS mediated by competitive interaction with {alpha}-actinin-4 and calmodulin
FASEB J, May 1, 2008; 22(5): 1450 - 1457.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
G. Paroni, N. Cernotta, C. Dello Russo, P. Gallinari, M. Pallaoro, C. Foti, F. Talamo, L. Orsatti, C. Steinkuhler, and C. Brancolini
PP2A Regulates HDAC4 Nuclear Import
Mol. Biol. Cell, February 1, 2008; 19(2): 655 - 667.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.